| Martina F Mutone, MD | |
|
14300 E 138th Ste A, Fishers, IN 46037-0051 | |
| (317) 813-1660 | |
| (317) 813-1667 |
| Full Name | Martina F Mutone |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 30 Years |
| Location | 14300 E 138th Ste A, Fishers, Indiana |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1619981545 | NPI | - | NPPES |
| P00220118 | Other | IN | MEDICARE RAILROAD |
| 000000359695 | Other | IN | ANTHEM |
| 200498030 | Medicaid | IN |
| Facility Name | Location | Facility Type |
|---|---|---|
| Community Hospital North | Indianapolis, IN | Hospital |
| Community Hospital East | Indianapolis, IN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Urology Of Indiana Llc | 7517870009 | 65 |
News Archive
Avi Dor, Ph.D., professor in the Department of Health Policy, GW School of Public Health and Health Services, was a co-author of a study, in collaboration with Teva Pharmaceuticals, that found that higher patient adherence to disease modifying therapies, like glatiramer acetate (GA), an immunomodulator drug currently used to treat multiple sclerosis, reduced inpatient costs, outpatient costs, and other medical expenses in a national sample of multiple sclerosis patients.
Vical Incorporated announced today the issuance of two Canadian patents on the company's core technology, which involves direct administration of polynucleotide genetic material such as DNA or RNA.
A natural enzyme derived from human blood plasma showed potential in significantly reducing the effects of graft-vs.-host disease, a common and deadly side effect of lifesaving bone marrow transplants.
The National Patient Safety Foundation recognizes vaccine-preventable diseases as a matter of patient safety and supports mandatory influenza vaccination of health care workers to protect the health of patients, health care workers, and the community.
Thomas Vaughan, M.D., head of the Epidemiology Program in the Public Health Sciences Division of Fred Hutchinson Cancer Research Center, has received a three-year, $7.9 million grant from the National Cancer Institute to study genetic susceptibility for Barrett's esophagus and esophageal adenocarcinoma, a rapidly fatal cancer whose incidence has increased more than 500 percent in the past 30 years, faster than any other cancer in the United States.
› Verified 2 days ago
| Entity Name | Urology Of Indiana Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1487680518 PECOS PAC ID: 7517870009 Enrollment ID: O20031111000154 |
News Archive
Avi Dor, Ph.D., professor in the Department of Health Policy, GW School of Public Health and Health Services, was a co-author of a study, in collaboration with Teva Pharmaceuticals, that found that higher patient adherence to disease modifying therapies, like glatiramer acetate (GA), an immunomodulator drug currently used to treat multiple sclerosis, reduced inpatient costs, outpatient costs, and other medical expenses in a national sample of multiple sclerosis patients.
Vical Incorporated announced today the issuance of two Canadian patents on the company's core technology, which involves direct administration of polynucleotide genetic material such as DNA or RNA.
A natural enzyme derived from human blood plasma showed potential in significantly reducing the effects of graft-vs.-host disease, a common and deadly side effect of lifesaving bone marrow transplants.
The National Patient Safety Foundation recognizes vaccine-preventable diseases as a matter of patient safety and supports mandatory influenza vaccination of health care workers to protect the health of patients, health care workers, and the community.
Thomas Vaughan, M.D., head of the Epidemiology Program in the Public Health Sciences Division of Fred Hutchinson Cancer Research Center, has received a three-year, $7.9 million grant from the National Cancer Institute to study genetic susceptibility for Barrett's esophagus and esophageal adenocarcinoma, a rapidly fatal cancer whose incidence has increased more than 500 percent in the past 30 years, faster than any other cancer in the United States.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Martina F Mutone, MD 679 E County Line Rd, Greenwood, IN 46143-1049 Ph: (317) 890-2000 | Martina F Mutone, MD 14300 E 138th Ste A, Fishers, IN 46037-0051 Ph: (317) 813-1660 |
News Archive
Avi Dor, Ph.D., professor in the Department of Health Policy, GW School of Public Health and Health Services, was a co-author of a study, in collaboration with Teva Pharmaceuticals, that found that higher patient adherence to disease modifying therapies, like glatiramer acetate (GA), an immunomodulator drug currently used to treat multiple sclerosis, reduced inpatient costs, outpatient costs, and other medical expenses in a national sample of multiple sclerosis patients.
Vical Incorporated announced today the issuance of two Canadian patents on the company's core technology, which involves direct administration of polynucleotide genetic material such as DNA or RNA.
A natural enzyme derived from human blood plasma showed potential in significantly reducing the effects of graft-vs.-host disease, a common and deadly side effect of lifesaving bone marrow transplants.
The National Patient Safety Foundation recognizes vaccine-preventable diseases as a matter of patient safety and supports mandatory influenza vaccination of health care workers to protect the health of patients, health care workers, and the community.
Thomas Vaughan, M.D., head of the Epidemiology Program in the Public Health Sciences Division of Fred Hutchinson Cancer Research Center, has received a three-year, $7.9 million grant from the National Cancer Institute to study genetic susceptibility for Barrett's esophagus and esophageal adenocarcinoma, a rapidly fatal cancer whose incidence has increased more than 500 percent in the past 30 years, faster than any other cancer in the United States.
› Verified 2 days ago
Dr. Shirley A Thomas, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 13914 Southeastern Pkwy, Suite 314, Fishers, IN 46037 Phone: 317-872-1415 Fax: 317-337-2571 | |
Mrs. Caroline Christine Mecker, DO Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 13914 Southeastern Pkwy Ste 110, Fishers, IN 46037 Phone: 317-415-9010 | |
Denise N Rehfuss, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 12381 Wheathill Pass, Fishers, IN 46037 Phone: 419-819-6512 | |
Dr. Amy Hoffman Dodson, DO Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 13914 Southeastern Pkwy Ste 110, Fishers, IN 46037 Phone: 317-415-9010 | |
David Kiley, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 12164 Steepleview Ct, Fishers, IN 46037 Phone: 317-000-0000 | |
Dr. Susan L Benson, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 13914 Southeastern Pkwy Ste 110, Fishers, IN 46037 Phone: 317-415-9010 | |
Micah T Mathai, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 13100 E 136th St Ste 2400, Fishers, IN 46037 Phone: 317-328-6620 |